AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 72 min read$OPCH

Option Care stock surges on McKesson's home-infusion bet

Option Care Health (OPCH) shares rose 33% to $31.11 after McKesson (MCK) and Clayton, Dubilier & Rice agreed to take it private for $32.05 per share, valuing it at $5.8B. McKesson will initially own 49%, with an option to acquire the rest later. The deal gives McKesson access to Option Care's home-infusion network, serving 315K+ patients. Option Care's Q2 revenue grew 1.9% to $1.44B. The deal needs shareholder and regulatory approvals to close in early 2027.

Original reporting
finance.yahoo.com
Published Oct 7, 2026, 5:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 5:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Option Care stock surges on McKesson's home-infusion bet — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$OPCHNeutralHigh
01

Why it matters

The deal creates a strategic foothold for McKesson in home infusion and may drive sector consolidation.

02

Market read

A large‑scale M&A in the healthcare sector with immediate price impact and long‑term strategic implications.

03

What to watch

Regulatory approval risk and potential future acquisition cost for McKesson.

Relevance 9/10Novelty 9/10Timing: today

Background

The article reports the first public disclosure of the Option Care acquisition by McKesson and CD&R.

Company-level read

Ticker impact

$OPCHNeutralHigh confidence
Context

Option Care announced a $5.8B cash acquisition, causing its shares to surge 33% before delisting.

Expected impact

likely pressure as the market prices in the cash premium and eventual delisting.

Evidence & confidence

The deal is newly disclosed, premium is sizable, and the stock will be taken private.

$MCKNeutralHigh confidence
Context

McKesson disclosed a $1.4B minority stake purchase in Option Care, expanding its home‑infusion network.

Expected impact

potential modest upside as investors value the new network exposure.

Evidence & confidence

The transaction is newly announced and adds a new revenue channel for McKesson.

Market effects

Sector

Strengthens the specialty‑care and home‑infusion sector, signaling consolidation.

Regional

U.S. healthcare services market sees increased M&A activity.

Global

Highlights trend of shifting complex therapies to outpatient settings worldwide.

Counterpoint

What could challenge this read

The premium may be excessive if integration costs rise, suggesting caution.

Key entities

  • Company
    Option Care Health

    Home‑infusion provider being taken private.

  • Company
    McKesson Corporation

    Pharmaceutical distributor acquiring a minority stake.

  • Private Equity
    Clayton, Dubilier & Rice

    Acquires majority ownership of Option Care.

Read at source← All news

Also covered by

4 outlets

Related articles

OCT 7
$OPCHHighAI 9/10

Infusion therapy provider being acquired in $5.8 billion deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson in a $5.8 billion deal, expected to close in early 2027. CD&R will hold majority ownership, with McKesson holding a minority stake. Option Care Health shares were trading at $31.02, up from $23.34 before the acquisition news. The company will remain separate but will delist from Nasdaq post-deal.

wfmz.com2 min
OCT 7
$MCKHighAI 9/10

McKesson Plans $1.4 Billion Stake in $5.8 Billion Option Care Buyout

McKesson plans a $1.4B investment for a 49% stake in Option Care Health, part of a $5.8B buyout by Clayton, Dubilier & Rice. Shareholders will receive $32.05 per share. The deal, pending approvals, is expected to close in early 2027. Option Care shares rose 32.7% on the news. McKesson's Q1 revenue grew 8% to $105.4B, with net income down 22% to $614M.

finchannel.com2 min
OCT 7
$MCKHighAI 9/10

McKesson, private equity firm buy home infusion company, Option Care Health

McKesson Corporation and private equity firm Clayton Dubilier & Rice (CD&R) agreed to acquire Option Care Health, a home infusion company, for $5.8 billion. McKesson will invest $1.4 billion for a 49% stake, with CD&R taking 51%. The deal values Option Care Health at $32.05 per share, a 36% premium over Monday's closing price. Once completed, Option Care Health will become private and delist from Nasdaq.

managedhealthcareexecutive.com2 min